AML With FLT3 Mutation
1 competing product in clinical development for AML With FLT3 Mutation.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Gilteritinib + Cytarabine + Mitoxantrone + Etoposide + G-CSF + Fludarabine | Astellas Pharma | Phase 3 | Active | 44 |